New investigational drug for treatment of Myelofibrosis

Trial ID:
IRB-24-8484
Marin Xavier, MD

Inclusion Criteria

Patients must:

  • Be 18 years or older
  • Have confirmed diagnosis of Myelofibrosis
  • Be able to complete study questionnaires

Exclusion Criteria

Patients must not:

  • Have prior therapy with any JAK inhibitor
  • Have prior splenectomy
  • Have history of solid organ transplant
  • Have other malignancy within the last three years

Additional Info

All treatments and physician visits during this study will take place at Prebys Cancer Center in Hillcrest.

For more information search NCT#: 06479135 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org